← Back
$LGND All transactions

LIGAND PHARMACEUTICALS INC

▼ SELL

$ Value

$753K

Shares

4,418

Price

$170

Filed

Sep 24

Insider

Name

Aryeh Jason

Title

CIK

0001376960

Roles

Director

Transaction Details

Transaction Date

2025-09-23

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

74,871

Footnotes

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $169.6625 to $170.6600. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $170.6850 to $171.6050. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $171.7250 to $172.2400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | All securities disclosed in this Form 4 are owned by certain funds managed by JALAA Equities, LP, JLV Investments, LP and affiliates (the "Funds"). Jason Aryeh is the General Partner of JALAA Equities, LP and a partner of JLV Investments, LP. By reason of the provisions of Rule 16a-1 under the Securities Exchange Act of 1934, as amended, JALAA Equities, LP, JLV Investments, LP and affiliates and Mr. Aryeh may be deemed to be the beneficial owners of the securities beneficially owned by the Funds.

Filing Info

Accession No.

0002001011-25-000082

Form Type

4

Issuer CIK

0000886163

Aryeh Jason's History

Date Ticker Type Value
2025-12-08 LGND M $141K
2025-12-08 LGND M $0
2025-09-23 LGND $753K
2025-09-23 LGND $791K
2025-09-23 LGND $164K
2025-09-19 OBIO $2K
2025-08-07 OBIO A $0
2025-07-15 LFCR A
2025-06-24 OBIO A $0
2025-06-24 OBIO A $0

Other Insiders at LGND (90d)

Insider Bought Sold Last
LAMATTINA JOHN L $434K 2026-03-06
KOZARICH JOHN W $94K 2026-04-01
Davis Todd C
Chief Executive Officer
2026-03-02
Sabba Stephen L $208K 2026-03-23
Espinoza Octavio
Chief Financial Officer
2026-03-02
Reardon Andrew
CLO & Secretary
$1.0M 2026-04-01